What BMI Do You Need For Mounjaro?
Quick Answer
To qualify for Mounjaro, you generally need a BMI of 30 or above, or a BMI of 27 or above alongside at least one weight related health condition such as type 2 diabetes or high blood pressure. BMI is an important starting point but not the only factor assessed, and a full medical consultation is required to confirm eligibility. Private prescribing criteria differ from NHS thresholds, so a consultation is the most reliable way to find out whether you qualify.
One of the first questions people ask when considering Mounjaro is whether their BMI makes them eligible for treatment. Body mass index is one of the key criteria used to assess suitability, but it is not the only factor, and understanding the full picture helps set more realistic expectations before booking a consultation.
Key points you should know are:
- A BMI of 30 or above is the primary threshold for Mounjaro eligibility
- A BMI of 27 or above may also qualify if you have a weight related health condition
- BMI is one of several factors assessed, not the only one
- Private eligibility criteria differ from NHS criteria in some respects
- A full medical assessment is required before any prescription is issued
If you are in Glasgow and want to find out whether you qualify, contact us or book a consultation with our team today.
Understanding BMI As A Starting Point
Body mass index is calculated by dividing a person’s weight in kilograms by their height in metres squared. It is a simple, widely used screening tool that categorises weight into ranges: underweight, healthy weight, overweight and obese. While BMI has limitations as a measure of health (it does not directly measure body fat, muscle mass or metabolic risk), it remains a standard and practical starting point for assessing eligibility for weight loss treatment.
The BMI thresholds used for Mounjaro eligibility in private settings are broadly aligned with the licensed indications for tirzepatide in the UK:
- BMI of 30 or above: eligible regardless of the presence of other conditions
- BMI of 27 to 29.9: eligible if at least one weight related health condition is present
What Weight Related Conditions Count?
For those with a BMI between 27 and 30, eligibility typically depends on the presence of at least one diagnosed weight related health condition. These commonly include:
- Type 2 diabetes or pre-diabetes
- High blood pressure (hypertension)
- High cholesterol or dyslipidaemia
- Obstructive sleep apnoea
- Non-alcoholic fatty liver disease
- Cardiovascular disease
- Polycystic ovary syndrome (PCOS)
The presence of one or more of these conditions, alongside a BMI of 27 or above, may make you eligible for private Mounjaro treatment. Your prescriber will confirm this at your consultation following a review of your medical history.
Why BMI Alone Does Not Tell The Whole Story
While BMI is a useful starting point, it has well recognised limitations. Two people with the same BMI can have very different body compositions, metabolic health profiles and health risks. Someone with a high proportion of muscle mass may have a BMI in the overweight range without carrying excess fat, while someone with a lower BMI may carry a higher proportion of body fat in a way that increases metabolic risk.
For this reason, a thorough clinical assessment looks beyond the BMI number to consider:
| Assessment factor | Why it matters |
|---|---|
| Waist circumference | Abdominal fat is associated with higher metabolic risk than fat elsewhere |
| Medical history | Previous conditions, medications and contraindications must be assessed |
| Weight related conditions | These affect both eligibility and the expected benefit of treatment |
| Current medications | Some medications interact with Mounjaro and must be reviewed |
| Treatment goals | Understanding what you want to achieve helps tailor the plan |
Waist Circumference As A Companion Measure
Alongside BMI, waist circumference is increasingly used in clinical assessments because abdominal fat specifically is more strongly associated with metabolic risk than fat distributed elsewhere on the body. High waist circumference, even at a BMI that falls within the overweight rather than obese category, can indicate a significantly elevated risk of type 2 diabetes, cardiovascular disease and other weight related conditions.
For this reason, some clinical assessments will measure waist circumference alongside BMI to build a more complete picture of metabolic health. In general, a waist circumference above 88cm for women and above 102cm for men is associated with significantly increased health risk, though these thresholds vary somewhat by ethnicity and clinical guideline.
Understanding this context helps explain why BMI alone is not always the definitive criterion in a clinical assessment and why a thorough consultation looks at multiple measures together rather than a single number.
What If Your BMI Is Just Below 30?
This is a common situation for people who are close to the threshold but do not quite reach it. In private prescribing, a BMI slightly below 30 without any weight related health conditions would generally not meet eligibility criteria for Mounjaro. However, if you have a relevant condition such as those listed above and your BMI is 27 or above, treatment may still be appropriate.
It is also worth noting that BMI calculations are sensitive to small changes in height or weight. If you are close to the threshold, having your BMI measured accurately at a consultation, rather than relying on a self-calculated figure based on recalled height, is worthwhile.
How Private Eligibility Differs From NHS Eligibility
NHS eligibility for Mounjaro in Scotland is generally stricter than private prescribing criteria, involving additional requirements around the presence of type 2 diabetes specifically and access through specialist tier 3 weight management services. Waiting times can be significant.
Private prescribing through a regulated pharmacy such as CarePoint Pharmacy applies the licensed eligibility criteria and carries out the same clinical assessment, but without the NHS referral pathway or waiting list. This gives eligible patients in Glasgow faster access to treatment under proper clinical supervision.
What Happens If You Do Not Meet The BMI Threshold?
If you do not currently meet the BMI threshold for Mounjaro, this does not necessarily mean weight loss support is not available to you. Alternative options may include:
- Lifestyle intervention and dietary support through the clinic
- Reviewing whether any weight related conditions may change your eligibility
- Discussing whether any other evidence based approaches suit your situation
- Re-assessment in the future if circumstances change
A consultation is always the right starting point, even if you are unsure whether you meet the criteria. Our team can assess your situation properly and advise on the most appropriate next step.
What The Assessment At CarePoint Pharmacy Involves
For Glasgow patients considering Mounjaro, the eligibility assessment at our clinic includes, followed by a structured plan beginning with the appropriate starting dose:
- Confirming your current BMI through accurate measurement
- Reviewing your full medical history and any relevant diagnoses
- Checking your current medications for any contraindications
- Discussing your weight management history and previous attempts
- Explaining what treatment involves, including the dose schedule and what to expect
- Confirming eligibility and issuing a prescription where appropriate
This thorough approach ensures that treatment is both clinically appropriate and safe for your individual circumstances, rather than simply meeting a BMI number on paper.
Tracking Your BMI Over Time During Treatment
Once treatment begins, monitoring changes in BMI over time provides one measure of progress, though it should not be the only one. As Mounjaro takes effect and appetite reduces, weight typically decreases gradually, which is reflected in a falling BMI. However, BMI alone does not capture changes in body composition, such as the preservation of muscle mass or reductions in visceral fat, which are equally important outcomes of treatment.
At CarePoint Pharmacy, progress monitoring looks at multiple markers rather than relying solely on the BMI number. This gives a more complete picture of how treatment is benefiting your health beyond the headline weight figure.
BMI And Comorbidities: A More Complete Picture
For many patients, the most significant benefit of Mounjaro treatment is not simply the change in BMI but the improvement in weight related health conditions alongside weight loss. Reductions in blood pressure, improvements in blood sugar control and cholesterol, reduced symptoms of sleep apnoea and improved energy levels are all outcomes that matter clinically alongside the change in body weight.
These improvements can begin to occur before a patient reaches their target weight or BMI, which is a further reason why eligibility assessment and ongoing monitoring looks at the whole health picture rather than the BMI number in isolation. Treatment success should be measured across all of these dimensions rather than only by whether a specific BMI threshold has been crossed. For a realistic picture of what results can look like over the early weeks, our guide to 8 week weight loss before and after on Mounjaro is worth reading before your consultation.
BMI Limitations And Why Clinical Judgement Matters
The limitations of BMI as a measure are well recognised in clinical practice. It was originally designed as a population level statistical tool, not as a diagnostic measure for individuals. For this reason, clinical assessment of weight and health involves additional measures that BMI alone cannot capture.
For example, two individuals at the same BMI but with different amounts of visceral abdominal fat, different muscle mass and different metabolic profiles will have very different health risk levels. This is why prescribers consider the full picture at assessment, including waist circumference, relevant blood markers where available, lifestyle factors and overall health context, rather than treating the BMI number as a definitive or complete assessment of whether treatment is appropriate.
Re-Assessment If Your Circumstances Change
BMI and health circumstances can change significantly over time. Someone who does not currently meet the eligibility threshold for Mounjaro may find that their BMI increases or that a weight related health condition is diagnosed that changes their eligibility picture. In these circumstances, a re-assessment consultation is worth arranging rather than assuming the previous result still applies.
Similarly, patients who begin treatment and then lose weight may find their BMI drops toward the lower eligibility threshold during treatment. This does not automatically mean treatment should stop, since the clinical benefit of continuing is assessed on an ongoing basis at reviews, but it is worth being aware of as an evolving consideration throughout the treatment journey.
Frequently Asked Questions
Can I qualify for Mounjaro with a BMI of 28 if I have high blood pressure?
Potentially yes. A BMI of 27 or above alongside a confirmed weight related health condition such as hypertension may meet private prescribing eligibility criteria. This would be confirmed at a full assessment.
Does ethnicity affect BMI thresholds for Mounjaro?
Some clinical guidelines use lower BMI thresholds for certain ethnic groups, particularly South Asian populations, where metabolic risk is higher at a lower BMI. This should be discussed with your prescriber as part of your assessment.
What if I have lost weight recently and my BMI has dropped slightly below 30?
This is assessed case by case. Your prescriber will consider your recent weight history and health context rather than applying the threshold rigidly without clinical judgement.
Is BMI the same as body fat percentage?
No. BMI is a proxy measure based on height and weight, while body fat percentage directly measures the proportion of fat tissue. A clinical assessment considers both alongside other health factors.
Will I be weighed and measured at the consultation?
Yes, accurate height and weight measurements are taken as part of the assessment to confirm your BMI rather than relying on self-reported figures.
Can I access Mounjaro privately if the NHS has refused me?
NHS and private prescribing criteria are different. An NHS refusal does not automatically mean you are ineligible privately, though a full assessment is still required to confirm suitability.
Ready to find out if you qualify? Contact our Glasgow team or book your eligibility assessment online today.
Disclaimer: This blog is intended as a general guide and does not replace personalised medical advice. Eligibility for Mounjaro must be confirmed through a full clinical assessment. Please visit us or contact us to discuss your individual circumstances.